DYRK1 inhibitor and its use

Title:

DYRK1 inhibitor and its use

Document Type and Number:

Japanese Patent JP6017559

Kind Code:

B2

Abstract:

The present invention relates to novel thiazolo[5,4-f]quinazoline compounds and methods that are useful in the amelioration, treatment or control of Down's syndrome or early Alzheimer's disease or in the amelioration, treatment or control of cancers, especially solid tumors. More specifically, the invention relates to DYRK1A and/or DYRK1B inhibitors and to methods for preparing such compounds.

More Like This:

WO/2023/137353	15-PGDH INHIBITORS
JP4668536	Pancreatic lipase inhibitor compound, its synthesis and use
JP2015511632	Administration of RAF and MEK inhibitors in the treatment of melanoma

Inventors:

Bertrand Lublon
Anne-Sophie Casagrande
Laurent Desire
Alicia Fucoul
Thierry Besson

Application Number:

JP2014525468A

Publication Date:

November 02, 2016

Filing Date:

August 17, 2012

Export Citation:

Click for automatic bibliography generation Help

Assignee:

DIAXONHIT

International Classes:

A61K31/519; C07D513/04; A61K31/5377; A61K45/00; A61P25/28; A61P35/00; A61P43/00

Foreign References:

GB2447791A
WO1995019970A1
WO2011041655A1
WO2010103240A1

Attorney, Agent or Firm:

Samejima Mutsumi
Nagatoshi Shinagawa
Yasushi Morimoto
Nishino Mitsuru

Previous Patent: A mobile communication system, a mobile communication method, and a base transceiver station

Next Patent: JPS6017560